NCT01910441View on ClinicalTrials.gov

Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients

PHASE4TerminatedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Vildagliptin

Vildagliptin 50 mg twice daily

DRUG

Glimepiride

Glimepiride 1-6 mg once daily

DRUG

Metformin

Metformin (1000-1500 mg daily)

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY